Page last updated: 2024-10-22

ambroxol and Diffuse Myofascial Pain Syndrome

ambroxol has been researched along with Diffuse Myofascial Pain Syndrome in 1 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Research Excerpts

ExcerptRelevanceReference
"Ambroxol is a secretolytic agent used in the treatment of various airway disorders."5.46Ambroxol for fibromyalgia: one group pretest-posttest open-label pilot study. ( Acosta, G; Barrera-Villalpando, MI; Becerril-Mendoza, LT; Martínez-Lavín, M; Martínez-Martínez, LA; Muñoz, OE; Pérez, LF; Rodríguez-Henriquez, P; Silveira, LH; Vargas, A, 2017)
"Ambroxol is a secretolytic agent used in the treatment of various airway disorders."1.46Ambroxol for fibromyalgia: one group pretest-posttest open-label pilot study. ( Acosta, G; Barrera-Villalpando, MI; Becerril-Mendoza, LT; Martínez-Lavín, M; Martínez-Martínez, LA; Muñoz, OE; Pérez, LF; Rodríguez-Henriquez, P; Silveira, LH; Vargas, A, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martínez-Martínez, LA1
Pérez, LF1
Becerril-Mendoza, LT1
Rodríguez-Henriquez, P1
Muñoz, OE1
Acosta, G1
Silveira, LH1
Vargas, A1
Barrera-Villalpando, MI1
Martínez-Lavín, M1

Other Studies

1 other study available for ambroxol and Diffuse Myofascial Pain Syndrome

ArticleYear
Ambroxol for fibromyalgia: one group pretest-posttest open-label pilot study.
    Clinical rheumatology, 2017, Volume: 36, Issue:8

    Topics: Adult; Ambroxol; Analgesics; Female; Fibromyalgia; Humans; Middle Aged; Pain Measurement; Pilot Proj

2017